8 completed, 1 enrolling by invitation, 1 recruiting, 1 terminated. 5 Phase 1, 4 Phase 2, 3 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Terminated 1, Unknown 1 |
| Phase 2 | 4 | Completed 2, Recruiting 1, Unknown 1 |
| Not applicable | 3 | Completed 2, Withdrawn 1 |
| Phase 3 | 2 | Completed 2 |
Follow Norditropin: new trials by email Literature Review of Norditropin trials Research Report on Norditropin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT) Recombinant human growth hormone - Gulf War Syndrome, Adult Growth Hormone Deficiency | Phase 2 | Recruiting | Baylor College of Medicine | 20 | 2024-03-11 | 2026-05-08 |
| French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome Norditropin - Noonan Syndrome | Enrolling by invitation | Novo Nordisk A/S | 221 | 2022-03-16 | 2026-10-08 | |
| Skeletal Muscle Effects of GH in Boys Somatropin injection - Growth Hormone Deficiency, Idiopathic Short Stature | Completed | Nemours Children's Clinic | 45 | 2019-07-22 | 2025-11-04 | |
| Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children Y-shape pegylated somatropin, Norditropin®, Norditropin - Growth Hormone Deficiency | Phase 2 / Phase 3 | Completed | Xiamen Amoytop Biotech Co., Ltd. | 434 | 2018-12-26 | 2024-01-24 |
| Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency Norditropin - Short Stature | Phase 1 / Phase 2 | Completed | Children's Hospital Medical Center, Cincinnati | 22 | 2018-02-01 | 2024-07-30 |
| Study of Testosterone and rHGH in FSHD Testosterone Enanthate, Somatropin - Facioscapulohumeral Muscular Dystrophy | Phase 1 | Completed | University of Rochester | 20 | 2017-12-18 | 2023-05-16 |
| A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency somapacitan, Norditropin - Growth Hormone Disorder, Adult Growth Hormone Deficiency | Phase 3 | Completed | Novo Nordisk A/S | 62 | 2017-03-03 | 2020-11-23 |
| Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF Human Growth Hormone, Follicle Stimulating Hormone - Female Infertility Due to Diminished Ovarian Reserve | Phase 1 / Phase 2 | Unknown | Center for Human Reproduction | 30 | 2014-08-01 | 2020-02-18 |
| Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection. Insulin withdrawal, Norditropin - Diabetes Mellitus Type I, Ketoacidosis | Not applicable | Completed | University of Aarhus | 9 | 2014-05-01 | 2016-02-24 |
| Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome. Norditropin - Metabolic Syndrome | Not applicable | Withdrawn | Oregon Health and Science University | 2010-10-01 | 2013-02-20 | |
| Importance of the GH/IGF-1 Axis for Human Substrate and Energy Metabolism During Calorie Restriction GH hormone infusion, 42 hour fast, 12 hour fast - Healthy | Not applicable | Completed | University of Aarhus | 10 | 2010-09-01 | 2011-09-13 |
| Initiating Transdermal Estradiol Therapy in Turner's Syndrome Norditropin, Menostar 14mcg patch, Vivelle dot 25mcg patch - Turner's Syndrome | Phase 1 | Terminated | University of Chicago | 1 | 2009-04-01 | 2014-03-11 |
| Growth Hormone Administration and the Human Immune System Norditropin, Placebo - Healthy Volunteers | Phase 1 | Completed | National Institute on Aging (NIA) | 66 | 2006-10-19 | 2026-10-16 |
Dwarfism, Pituitary (4) · Dwarfism (2) · Diabetes Mellitus, Type 1 (1) · Fasting (1) · Insulin Resistance (1) · Ketosis (1) · Metabolic Syndrome (1) · Muscular Dystrophy, Facioscapulohumeral (1) · Noonan Syndrome (1) · Persian Gulf Syndrome (1) · Primary Ovarian Insufficiency (1) · Turner Syndrome (1)
Novo Nordisk A/S (2) · University of Aarhus (2) · Baylor College of Medicine (1) · Center for Human Reproduction (1) · Children's Hospital Medical Center, Cincinnati (1) · National Institute on Aging (NIA) (1) · Nemours Children's Clinic (1) · Oregon Health and Science University (1) · University of Chicago (1) · University of Rochester (1) · Xiamen Amoytop Biotech Co., Ltd. (1)
United States (8) · Denmark (2) · China (1) · France (1) · Japan (1)
Chad R Heatwole, MD, MS-CI (1) · Chee W Chia, M.D. (1) · David H Barad, MD (1) · Kevin C. Yuen, MRCP(UK), MD (1) · Nelly Mauras, MD (1) · Norbert Gleicher (1) · Philippe Backeljauw, MD (1) · Ricardo Jorge, MD (1) · Robert L. Rosenfield, MD (1) · Thomas Voss, MD (1) · Xiaoping Luo, MD, Ph.D (1)
PMID 24148194, PMID 30506451, PMID 31668393, PMID 32603494, PMID 33074729, PMID 34808697, PMID 34922359, PMID 35001504, PMID 36034448, PMID 36380045, PMID 37554078, PMID 40900971